 OXNARD, Calif.--BUSINESS WIRE--CURE Pharmaceutical Holding Corp. CURE or the Company OTC: CURR, a vertically integrated drug delivery and product development company, announced today that it has launched a new initiative for the clinical development of psychedelic compounds such as psilocybin, LSD, and MDMA for the treatment of various mental health disorders. Utilizing CUREs patented oral film platform CUREfilm for precision dosing, the company intends to optimize the absorption an 